AU7254494A - 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain - Google Patents

5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain

Info

Publication number
AU7254494A
AU7254494A AU72544/94A AU7254494A AU7254494A AU 7254494 A AU7254494 A AU 7254494A AU 72544/94 A AU72544/94 A AU 72544/94A AU 7254494 A AU7254494 A AU 7254494A AU 7254494 A AU7254494 A AU 7254494A
Authority
AU
Australia
Prior art keywords
antagonists
pain
treatment
disorders associated
peripheral disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72544/94A
Inventor
Philippe Danjou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU7254494A publication Critical patent/AU7254494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU72544/94A 1993-07-08 1994-07-06 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain Abandoned AU7254494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9314174 1993-07-08
GB939314174A GB9314174D0 (en) 1993-07-08 1993-07-08 5-ht3-antagonists
PCT/US1994/007488 WO1995001793A2 (en) 1993-07-08 1994-07-06 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain

Publications (1)

Publication Number Publication Date
AU7254494A true AU7254494A (en) 1995-02-06

Family

ID=10738511

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72544/94A Abandoned AU7254494A (en) 1993-07-08 1994-07-06 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain

Country Status (3)

Country Link
AU (1) AU7254494A (en)
GB (1) GB9314174D0 (en)
WO (1) WO1995001793A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048581A2 (en) 1999-02-18 2000-08-24 Novartis Ag Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
EP1419161A1 (en) 2001-08-24 2004-05-19 PHARMACIA & UPJOHN COMPANY Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611976B2 (en) * 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
GB8922622D0 (en) * 1989-10-07 1989-11-22 Wyeth John & Brother Ltd Aroylureas
GB2236751B (en) * 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
DE4009565A1 (en) * 1990-03-24 1991-09-26 Merck Patent Gmbh INDOLDER DERIVATIVES

Also Published As

Publication number Publication date
GB9314174D0 (en) 1993-08-18
WO1995001793A3 (en) 1995-03-30
WO1995001793A2 (en) 1995-01-19

Similar Documents

Publication Publication Date Title
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
AU4342997A (en) Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders
AU1173195A (en) Treatment of immunoregulatory disorders
AU6916694A (en) Novel treatments for allergic diseases
AU3459689A (en) Treatment of skin disorders
EP0765663A3 (en) Use of dienogest for the manufacture of a medicament for the treatment of the skin by topical application
AU4131296A (en) Treatment of disorders with duloxetine
AU4530989A (en) Pharmaceutical composition for the treatment of cerebral edema
AU3046897A (en) Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
AU6241096A (en) A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders
AU1249395A (en) Topical treatment of ocular photophobia
AU5340594A (en) Skin treatment
AU5518694A (en) Treatment of a group of related disorders
AU1727297A (en) Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
AU4202096A (en) The use of sertraline to treat cancer patients
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU2068295A (en) Skin treatment composition
AU6147296A (en) Therapeutic use of acetazolamide for the treatment of brain edema
AU7254494A (en) 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain
AU4081393A (en) Medicaments for the treatment of anxiety
AU1727397A (en) Application of pyrrolidine derivatives to the preparation of medicaments for the treatment of drug abuse
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis
AU7383994A (en) Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases
AU5397994A (en) Treatment of skin disorders